Survival Validation and Gene Mutations of N Descriptors in the Ninth Edition of the TNM Classification for Lung Cancer

Recruiting

• Conditions: Non-small Cell Lung Cancer

• Registration Number: NCT06349252
• Lead Sponsor: Fudan University

Brief Summary

The International Association for the Study of Lung Cancer Staging Committee recently unveiled the ninth edition of TNM staging system for lung cancer. This study aims to explore survival outcomes, stage grouping, and gene mutations in N descriptors of this new classification system.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-01
• Status Verified: 2024-03
• Study First Submitted: 2024-03-31
• Study First Submitted QC: 2024-03-31
• Last Update Submitted: 2024-03-31
• Study First Posted: 2024-04-05
• Last Update Posted: 2024-04-05
• Primary Completion: 2024-08-01
• Study Completion: 2025-01-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1263

Inclusion Criteria

Pathological N2.

Exclusion Criteria

Patients undergoing neoadjuvant chemotherapy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall Survival	Five year

Trial Locations

Locations (1)

Fudan University Cancer Center; 🇨🇳 Shanghai, Shanghai, China